Guideline for anti-TNF-alpha therapy in psoriatic arthritis

Rheumatology (Oxford). 2005 Mar;44(3):390-7. doi: 10.1093/rheumatology/keh514. Epub 2005 Feb 3.
No abstract available

Publication types

  • Guideline
  • Practice Guideline
  • Review

MeSH terms

  • Algorithms
  • Antibodies, Monoclonal / therapeutic use
  • Antirheumatic Agents / adverse effects
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Psoriatic / drug therapy*
  • Etanercept
  • Humans
  • Immunoglobulin G / therapeutic use
  • Immunosuppressive Agents / therapeutic use
  • Infliximab
  • Isoxazoles / therapeutic use
  • Leflunomide
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Sulfasalazine / therapeutic use
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Immunoglobulin G
  • Immunosuppressive Agents
  • Isoxazoles
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Sulfasalazine
  • Infliximab
  • Leflunomide
  • Etanercept